| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439247 | EBioMedicine | 2016 | 5 Pages |
Abstract
Clinical information and baseline clinical characteristics do not allow a reliable prediction of which trajectory the patients will follow after bDMARD initiation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
D.S. Courvoisier, D. Alpizar-Rodriguez, J.E. Gottenberg, M.V. Hernandez, F. Iannone, E. Lie, M.J. Santos, K. Pavelka, C. Turesson, X. Mariette, D. Choquette, M.L. Hetland, A. Finckh,